MedPath

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Phase 3
Conditions
Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
Interventions
Registration Number
NCT00715637
Lead Sponsor
Antisoma Research
Brief Summary

Amonafide is a DNA intercalating agent and inhibitor of topoisomerase II that has been extensively studied in patients with malignant solid tumors. Amonafide has also been studied in patients with AML.

The purpose of this study is to assess the relative efficacy and safety of amonafide in combination with cytarabine compared to daunorubicin with cytarabine in subjects with documented secondary AML.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
420
Inclusion Criteria
  • Diagnosis of AML according to WHO diagnostic criteria (at least 20% blasts in the peripheral blood or bone marrow), with FAB classification other than M3 (Acute Promyelocytic Leukemia), documented by bone marrow aspiration and biopsy performed within 14 days prior to administration of 1st dose of remission induction chemotherapy;
  • Either: Known and documented exposure to specific leukemogenic therapy of a specified nature for a non-myeloid condition; OR Documented diagnosis of MDS according to WHO criteria for at least 3 months prior to study entry, with prior bone marrow aspirate, biopsy and peripheral blood smear documenting MDS available to be submitted for subsequent central pathology review.
  • Age 18 years or older;
  • Eastern Cooperative Oncology Group (ECOG) performance score =< 2;
  • Fertile sexually active patients (men and women) must use an effective method of contraception which must be continued throughout the study.
  • Women of childbearing potential must have a negative serum pregnancy test.
  • Left Ventricular Ejection Fraction (LVEF) >= 50%, as determined by multiple-gated acquisition scan (MUGA) or echocardiogram (ECHO) within 14 days prior to administration of 1st dose of remission induction chemotherapy;
  • Adequate renal function as evidenced by the following laboratory test, obtained within 10 days prior to administration of 1st dose of remission induction chemotherapy: Serum creatinine =< 1.5 x ULN;
  • Adequate hepatic function as evidenced by the following laboratory tests, obtained within 10 days prior to administration of 1st dose of remission induction chemotherapy (unless attributed to hepatic involvement with AML): Total serum bilirubin =< 1.5 x ULN;Serum AST and ALT =< 1.5 x ULN;
  • Ability of the patient to participate fully in all aspects of this clinical trial;
  • Written Informed Consent and HIPAA authorization (USA sites only) must be obtained and documented.
Exclusion Criteria
  • Histologic diagnosis of FAB M3 Acute Promyelocytic Leukemia;
  • Clinically active CNS leukemia;
  • Prior induction therapy for AML;
  • Known HIV positive;
  • Known active hepatitis B or C, or any other active liver disease;
  • Patients with parenchymal abnormality on screening chest x-ray must have no evidence of pulmonary infection on chest tomography (CT) prior to starting remission induction therapy.
  • Any major surgery or radiation therapy within 4 weeks prior to study entry;
  • Prior cytotoxic chemotherapy for MDS within 4 weeks prior to study entry (patients with rapidly rising blast count may be enrolled within 4 weeks of prior cytotoxic chemotherapy with waiver from the Medical Monitor);
  • Persistent chronic non-hematologic toxicity (other than alopecia) greater than grade 1 from prior therapy for MDS;
  • Serious concomitant illnesses (for example, pulmonary infiltrate, unstable angina or myocardial infarction or stroke within 3 months prior to study entry, congestive heart failure AHA class 2 or greater, uncontrolled hypertension, uncontrolled diabetes, actively bleeding gastric ulcer, etc.), which in the investigator's opinion would not make the patient a good candidate for the trial;
  • Pregnant or breast feeding;
  • History of clinically significant allergic reactions attributed to compounds of similar chemical or biological composition to amonafide, cytarabine or daunorubicin;
  • Prior enrollment in this trial;
  • Any other known condition (e.g., familial, sociological, or geographical) or behavior (including substance dependence or abuse, psychological or psychiatric illness), which in the investigator's opinion would make the patient a poor candidate for the trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm BDaunorubicin and CytarabineDaunorubicin in Combination with Cytarabine
Arm AAmonafide and CytarabineAmonafide in Combination with Cytarabine
Primary Outcome Measures
NameTimeMethod
Rate of CR + CRi (which includes CRc and CRd) will be determined by assessing the proportion of patients who achieved CR or CRi among all evaluable patients.Course 1/Course 2 Day 37 bone marrow assessments and confirmation bone marrow 30 days later
Secondary Outcome Measures
NameTimeMethod
Median duration of remission and median duration of disease free survival.Follow-up visits following post-remission therapy

Trial Locations

Locations (158)

Univ of Southern California Comprehensive Cancer Center

🇺🇸

Los Angeles, California, United States

Taussig Cancer Center, Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Winship Cancer Institute, Emory University

🇺🇸

Atlanta, Georgia, United States

The Blood and Marrow Transplant Group of GA

🇺🇸

Atlanta, Georgia, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Royal Perth Hospital

🇦🇺

Perth, Western Australia, Australia

LSU Health Sciences Center, Feist-Weiller Cancer Center

🇺🇸

Shreveport, Louisiana, United States

Dana Farber Cancer Institute

🇺🇸

Boston, Massachusetts, United States

Hospital Italiano de La Plata

🇦🇷

Buenos Aires, Argentina

Algemeen Ziekenhuis Sint-Jan

🇧🇪

Brugge, Belgium

Hospital Dr. Gustavo Fricke

🇨🇱

Viña del Mar, Chile

Hospital Militar

🇪🇨

Quito, Ecuador

Box Hill Hospital

🇦🇺

Box Hill, Victoria, Australia

Sanatorio Parque

🇦🇷

Rosario - Santa Fe, Argentina

Landesklinikum St. Polten

🇦🇹

St. Polten, Austria

University Hospital Kralovske Vinohrady Prague

🇨🇿

Prague, Czech Republic

Hadassah Medical Center

🇮🇱

Jerusalem, Israel

Coltea Clinical Hospital

🇷🇴

Bucharest, Romania

The Canberra Hospital

🇦🇺

Garran, Australian Capital Territory, Australia

Penn State Hershey Medical Center

🇺🇸

Hershey, Pennsylvania, United States

Hospital General de Agudos "Dr. Teodoro Alvarez"

🇦🇷

Ciudad Autónoma de Bs. As., Argentina

University Hospital Gent

🇧🇪

Gent, Belgium

UCL de Mont-Godinne

🇧🇪

Yvoir, Belgium

Hospital Santa Maria

🇨🇱

Santiago, Chile

General University Hospital Prague

🇨🇿

Prague, Czech Republic

Provincial Hospital in Opole

🇵🇱

Opole, Poland

State Higher Educational Institution St. Petersburg State Medical University n.a. I.P. Pavlov under the Federal Agency for Healthcare and Social Development

🇷🇺

St. Petersburg, Russian Federation

National Cheng Kung University Hospital (NCKUH)

🇨🇳

Tainan, Taiwan

Odesa Regional Clinical Hospital

🇺🇦

Odesa, Ukraine

Cancer Center of the Carolinas

🇺🇸

Greenville, South Carolina, United States

Landeskrankenhaus Salzburg

🇦🇹

Salzburg, Austria

Kaposi Mór County Teaching Hospital

🇭🇺

Kaposvár, Hungary

Chaim Sheba Medical Center

🇮🇱

Tel Hashomer, Israel

Teaching Hospital of the Medical University in Bialystok

🇵🇱

Bialystok, Poland

Colentina Clinical Hospital, Internal Medicine Department

🇷🇴

Bucharest, Romania

Sibiu County Clinical Hospital, Internal Clinic II

🇷🇴

Sibiu, Romania

Chinese Medical University Hospital (CMUH)

🇨🇳

Taichung City, Taiwan

Peter MacCallum Cancer Centre

🇦🇺

Melbourne, Victoria, Australia

Institut Jules Bordet

🇧🇪

Brussels, Belgium

Hospital DIPRECA

🇨🇱

Santiago, Chile

University of Pecs

🇭🇺

Pecs, Hungary

Nicolaus Copernicus Provincial Specialist Hospital in Lodz

🇵🇱

Lodz, Poland

The Alfred Hospital

🇦🇺

Melbourne, Victoria, Australia

Szent Istvan and Szent Laszlo Corporate Hospital - Out-patient Clinic of the Municipality Government

🇭🇺

Budapest, Hungary

Academic Clinical Centre - Teaching Hospital of the Medical University of Gdansk

🇵🇱

Gdansk, Poland

Poznan Stare Miasto Health Care Facility

🇵🇱

Poznan, Poland

Military Institue of Health Services

🇵🇱

Warsaw, Poland

Institute of Hematology and Transfusiology

🇵🇱

Warsaw, Poland

Fundeni Clinical Institute "Stefan Berceanu" Center for Hematology and Bone Marrow Transplant

🇷🇴

Bucharest, Romania

State Medical Institution Republican Hospital n.a. V.A. Baranov

🇷🇺

Petrozavodsk, Republic of Karelia, Russian Federation

State Medical Institution Irkutsk Regional Clinical Hospital

🇷🇺

Irkutsk, Russian Federation

State Medical Institution Territorial Clinical Oncological Center

🇷🇺

Krasnodar, Russian Federation

M.I. Pyrohov Vinnytsya Regional Clinical Hospital

🇺🇦

Vinnytsya, Ukraine

Veterans General Hospital Taipei (VGH-TP)

🇨🇳

Taipei, Taiwan

Brasov County Emergency Clinical Hospital

🇷🇴

Brasov, Romania

State Medical Institution Leningrad Regional Clinical Hospital

🇷🇺

St. Petersburg, Russian Federation

Federal Center of Heart, Blood and Endocrinology

🇷🇺

St. Petersburg, Russian Federation

Changhua Christian Hospital (CCH)

🇨🇳

Changhua, Taiwan

Public Institution 'Cherkasy Regional Oncology Center'

🇺🇦

Cherkasy, Ukraine

Ivano-Frankivsk State Medical University

🇺🇦

Ivano-Frankivsk, Ukraine

State Institution 'Institute of Blood Pathology and Transfusion Medicine under the UAMS'

🇺🇦

Lviv, Ukraine

National Taiwan University Hospital (NTUH)

🇨🇳

Taipei, Taiwan

Municipal Medical Institution Municipal Hospital #1

🇷🇺

Cherepovets, Russian Federation

Mykolaiv Regional Clinical Hospital

🇺🇦

Mykolaiv, Ukraine

Ukrainian Medical Academy of Dentistry

🇺🇦

Poltava, Ukraine

O.F. Herbachevsky Zhytomyr Regional Clinical Hospital

🇺🇦

Zhytomyr, Ukraine

University of California San Francisco

🇺🇸

San Francisco, California, United States

Rocky Mountain Blood and Marrow Transplant Program

🇺🇸

Denver, Colorado, United States

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

Oregon Health & Science University

🇺🇸

Portland, Oregon, United States

Intermountain Healthcare

🇺🇸

Salt Lake City, Utah, United States

Sarah Cannon Research Institute

🇺🇸

Nashville, Tennessee, United States

Universitätsklinikum Schleswig-Holstein

🇩🇪

Kiel, Germany

Northwestern University School of Medicine

🇺🇸

Chicago, Illinois, United States

Ospedale S. Eugenio

🇮🇹

Rome, Italy

Istituto Clinico Humanitas

🇮🇹

Rozzano, Italy

Ajou University Hospital

🇰🇷

Suwon, Korea, Republic of

Severance Hospital in YUHS

🇰🇷

Seoul, Korea, Republic of

Inje University Busan Paik Hospital

🇰🇷

Busan, Korea, Republic of

State Medical Institution Sverdlovsk Regional Clinical Hospital #1

🇷🇺

Ekaterinburg, Russian Federation

State Medical Institution Territorial Clinical Hospital #1

🇷🇺

Khabarovsk, Russian Federation

Rambam Medical Center

🇮🇱

Haifa, Israel

University of Brescia

🇮🇹

Brescia, Italy

A.O.U Careggi

🇮🇹

Firenze, Italy

Universitätsmedizin Mannheim

🇩🇪

Mannheim, Germany

Hospital Universitario La Fe

🇪🇸

Valencia, Spain

Università degli Studi di Roma "La Sapienza"

🇮🇹

Roma, Italy

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Petz Aladar County Teaching Hospital

🇭🇺

Győr, Hungary

Khmelnytsky Regional Hospital

🇺🇦

Khmelnytsky, Ukraine

A.O.U San Martino

🇮🇹

Genova, Italy

A.O. Cardarelli

🇮🇹

Napoli, Italy

A.O.U Pisana Santa Chiara

🇮🇹

Pisa, Italy

A.O. San Salvatore

🇮🇹

Pesaro, Italy

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Hospital de la Santa Creu I Sant Pau

🇪🇸

Barcelona, Spain

Churchill Hospital

🇬🇧

Oxford, United Kingdom

Janusz Korczak Provincial Specialist Hospital

🇵🇱

Slupsk, Poland

Independent Public University Hospital No. 1 in Wroclaw

🇵🇱

Wroclaw, Poland

Dr. Constantin Opris County Emergency Hospital, Internal Medicine Department

🇷🇴

Baia Mare, Romania

Hospital Del Mar

🇪🇸

Barcelona, Spain

Hospital Germans Trias i Pujol

🇪🇸

Badalona, Spain

Moscow State Medical Institution Municipal

🇷🇺

Moscow, Russian Federation

Hospital Vall d'Hebron

🇪🇸

Barcelona, Spain

Hospital Clinic I Provinicial

🇪🇸

Barcelona, Spain

Municipal Medical Institution

🇷🇺

Perm, Russian Federation

Chang Gung Memorial Hospital Kao Hsiung Branch

🇨🇳

Niao-Sung Hsiang, Kaohsiung Hsien, Taiwan

State Institution Russian Oncological Research Center n.a. N.N. Blokhin of the Russian Academy of Medical Sciences

🇷🇺

Moscow, Russian Federation

Mackay Memorial Hospital

🇨🇳

Taipei, Taiwan

State Higher Educational Instution Rostov State

🇷🇺

Rostow Am Don, Russian Federation

University Hospital of Wales

🇬🇧

Cardiff, Wales, United Kingdom

King's College Hospital

🇬🇧

London, United Kingdom

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

University of Iowa Hospitals

🇺🇸

Iowa City, Iowa, United States

UCLA Medical Center

🇺🇸

Los Angelas, California, United States

Roswell Park Cancer Institute

🇺🇸

Buffalo, New York, United States

Northshore Hospital - Monter Cancer Center

🇺🇸

Lake Success, New York, United States

Michigan State University

🇺🇸

Lansing, Michigan, United States

Western Pennsylvania Hospital

🇺🇸

Pittsburgh, Pennsylvania, United States

Roger Williams Medical Center

🇺🇸

Providence, Rhode Island, United States

Clinical Hematology Service

🇦🇷

Ciudad Autónoma de Bs. As., Argentina

Hospital Provincial de Cordoba

🇦🇷

Cordoba, Argentina

Westmead Hospital

🇦🇺

Westmead, New South Wales, Australia

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

Royal North Shore Hospital

🇦🇺

St Leonards, New South Wales, Australia

LKH-Universitats Klinikum Graz

🇦🇹

Graz, Austria

QEII Center for Clinical Research

🇨🇦

Halifax, Canada

London Health Sciences Centre

🇨🇦

London, Ontario, Canada

Charite - Campus Benjamin Franklin

🇩🇪

Berlin, Germany

The Ottawa Hospital - General Campus

🇨🇦

Ottawa, Canada

Institute of Haematology and Blood Transfusion Prague

🇨🇿

Prague, Czech Republic

Hospital Carlos Andrade Marin

🇪🇨

Quito, Ecuador

Hopital Sud

🇫🇷

Amiens, France

North Estonia Medical Centre Foundation

🇪🇪

Tallinn, Estonia

Instituto Ecuatoriano de Seguridad Social Hospital Regional Teodoro Maldonado Carbó

🇪🇨

Guayaquil, Ecuador

Hopital-DIEU

🇫🇷

Paris, France

Hopital de Versailles

🇫🇷

Versailles, Le Cheaney, France

Hopital Edouard Herriot

🇫🇷

Lyon, France

Hopital du Haut Leveque

🇫🇷

Pessac, France

Hopital Bretonneau - CHRU de Tours

🇫🇷

Tours, France

St Antonius Hospital

🇩🇪

Eschweiler, Germany

Asklepios Kliniken Altona

🇩🇪

Hamburg, Germany

Evangelische Kliniken GmbH

🇩🇪

Bonn, Germany

Campus Virchow Klinikum

🇩🇪

Berlin, Germany

Stadtische Kliniken Frankfurt

🇩🇪

Frankfurt, Germany

Universitatsklinikum Essen

🇩🇪

Essen, Germany

Medizin Hochschule Hannover

🇩🇪

Hannover, Germany

Klinikum Leverkusen

🇩🇪

Leverkusen, Germany

Markische Kliniken GmbH Klinikim Ludenscheid

🇩🇪

Lüdenscheid, Germany

Ewha Womans University Mokdong Hospital

🇰🇷

Seoul, Korea, Republic of

Dnipropetrovsk City General Clinical Hospital #4

🇺🇦

Dnipropetrovsk, Ukraine

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

University of Colorado Health Sciences Center

🇺🇸

Aurora, Colorado, United States

James Graham Brown Cancer Center

🇺🇸

Louisville, Kentucky, United States

University of Michigan Cancer Center

🇺🇸

Ann Arbor, Michigan, United States

Wake Forest University Health Sciences

🇺🇸

Winston-Salem, North Carolina, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Thomas Jefferson University

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath